Dianthus Therapeutics annual net debt
2021
2022
2023
2024
2025
Dianthus Therapeutics Net Debt Growth & History (DNTH)
Dianthus Therapeutics's net debt was −$49.7M for fiscal 2025.
View full Dianthus Therapeutics company overviewDianthus Therapeutics annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$49.7M | −$28.4M | — |
| 2024 | 2024-12-31 | −$21.3M | $110.4M | — |
| 2023 | 2023-12-31 | −$131.7M | −$146.3M | — |
| 2022 | 2022-12-31 | $14.6M | $146.2M | — |
| 2021 | 2021-12-31 | −$131.7M | — | — |
Dianthus Therapeutics quarterly net debt
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$109.3M | −$97.4M | — |
| Q1 2026 | 2026-03-31 | −$626.3M | −$617.6M | — |
| Q4 2025 | 2025-12-31 | −$49.7M | −$28.4M | — |
| Q3 2025 | 2025-09-30 | −$54.7M | −$21.3M | — |
| Q2 2025 | 2025-06-30 | −$11.9M | $301.9M | — |
| Q1 2025 | 2025-03-31 | −$8.7M | $320.5M | — |
| Q4 2024 | 2024-12-31 | −$21.3M | $110.4M | — |
| Q3 2024 | 2024-09-30 | −$33.4M | $123.3M | — |
| Q2 2024 | 2024-06-30 | −$313.8M | −$273.5M | — |
| Q1 2024 | 2024-03-31 | −$329.2M | −$306.0M | — |
| Q4 2023 | 2023-12-31 | −$131.7M | −$146.3M | — |
| Q3 2023 | 2023-09-30 | −$156.6M | −$150.5M | — |
| Q2 2023 | 2023-06-30 | −$40.3M | −$17.1M | — |
| Q1 2023 | 2023-03-31 | −$23.2M | $16.2M | — |
| Q4 2022 | 2022-12-31 | $14.6M | $146.2M | — |
| Q3 2022 | 2022-09-30 | −$6.1M | — | — |
| Q2 2022 | 2022-06-30 | −$23.2M | — | — |
| Q1 2022 | 2022-03-31 | −$39.4M | — | — |
| Q4 2021 | 2021-12-31 | −$131.7M | — | — |
Dianthus Therapeutics net debt trends
Between the periods ended 2021-12-31 and 2025-12-31, Dianthus Therapeutics's net debt increased from −$131.7M to −$49.7M, a change of $81.9M. The latest reported quarter, Q2 2026, shows −$109.3M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dianthus Therapeutics source filings ↗